Skip to content

Neuraxial and Neurolytic Analgesia for Intractable Pain

Neuraxial and Neurolytic Analgesia for Intractable Pain

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00167726
Enrollment
19
Registered
2005-09-14
Start date
2005-01-31
Completion date
2011-06-30
Last updated
2014-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

The purpose of this study is to collect longitudinal data on outcomes of neuraxial or neurolytic procedures in patients with intractable cancer and chronic noncancer pain so that we may contribute to the growing evidence for or against these therapies and to provide data for ongoing quality improvement activities.

Interventions

None listed

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* treated for intractable pain by the UW Interventional Pain Treatment program * inpatient or outpatient

Exclusion criteria

* less than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Prospective review of painsix yearsThe purpose of this study was to collect longitudinal data on outcomes of neuraxial or neurolytic procedures in patients with intractable cancer and chronic noncancer pain so that we may contribute to the growing evidence for or against these therapies and to provide data for ongoing quality improvement activities.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026